Search results for "Highlights"

Results 1 - 10 of about 112 for "Highlights".

PPI prophylaxis didn't affect 90-day mortality rates among ICU patients

An accompanying editorial described the study's secondary outcome findings as difficult to interpret but noted that the study highlights the low prevalence of gastrointestinal bleeding in modern ICUs.
October 2018

ACP Gastroenterology Monthly

HIGHLIGHTS. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus feugiat dui non mattis aliquam.

Scores to predict outcomes of upper GI bleeding compared

Researchers calculated three pre-endoscopy scores—admission Rockall, AIMS65, and Glasgow Blatchford—and two postendoscopy scores—full Rockall and PNED.
January 2017

Beta-blocker monotherapy may be preferred for primary prophylaxis of esophageal variceal bleeding

Guidelines currently recommend nonselective beta-blockers or variceal band ligation for primary prevention of variceal bleeding based on similar efficacy, but survival benefit may be better with the former treatment.
August 2018

ACP Gastroenterology Monthly introduces editorial advisory board

ACP Gastroenterology Monthly is pleased to introduce its editorial advisory board.
March 2017

Keeping tabs

Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with
May 2019

Rates of HDV co-infection may be higher than previously estimated

Patients with chronic hepatitis B virus (HBV) and hepatitis D virus (HDV) co-infection have the most severe form of viral hepatitis and are at much higher risk for cirrhosis and hepatocellular cancer than patients with HBV infection alone.
September 2018

Antidepressants may mitigate link between inflammatory bowel disease and depression

Patients with depression had more than double the risk of developing Crohn's disease or ulcerative colitis over a median follow-up of more than six years.
October 2018

Boxed warning added to liver disease drug

The FDA announced on Feb. 1 that it will add a new boxed warning to highlight the correct dosing for obeticholic acid (Ocaliva). ... The new warning will highlight current screening, dosing, and monitoring recommendations in the prescribing information
February 2018


An editorial said the results highlight the importance of alternative biologic treatments and regimens for some patients but noted that further research is needed on cost-effectiveness.
September 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next